GHK-Cu
peptideA copper peptide common in skin-care serums. Injectable versions are not approved.
Guide
Peptide serums, especially GHK-Cu, are commonly paired with microneedling online, but popularity is not proof of safety or benefit. FDA-authorized microneedling devices are not cleared to deliver cosmetics, drugs or blood products into the skin. A product made for intact skin should not be assumed to be sterile or appropriate for freshly punctured skin.

A microneedling device repeatedly inserts and removes small needles, creating many tiny punctures in the skin. FDA has authorized a limited number of devices for specific uses such as improving the appearance of facial acne scars, facial wrinkles and abdominal scars in adults age 22 and older. FDA

FDA says authorized medical microneedling devices have not been authorized for over-the-counter sale, and recommends choosing a healthcare professional trained in the procedure. FDA
Online routines group together several very different products. GHK-Cu, Matrixyl and Argireline are peptide ingredients; growth factors are proteins; exosomes are cell-derived vesicles; PDRN and polynucleotides are DNA fragments; and PRP is a person’s processed blood product. They should not be treated as one category.

| Product | What it is | What DiscoverMedica can establish |
|---|---|---|
| GHK-Cu / copper tripeptide-1 | A cosmetic copper-binding peptide | Topical evidence is limited; microneedling delivery is not FDA-cleared |
| Matrixyl or Argireline | Cosmetic peptide ingredients | A cosmetic label does not establish suitability for punctured skin |
| Growth-factor serum | A product containing signaling proteins | Formulation and evidence vary by product |
| Exosome product | A product marketed as containing cell-derived vesicles | Not interchangeable with peptides; claims require separate review |
| PDRN or polynucleotides | DNA-derived ingredients | Not peptides; regulatory status depends on the product and use |
| PRP | A blood product prepared from the patient | Not a peptide; microneedling devices are not cleared to deliver blood products |
GHK-Cu is the peptide most often paired with microneedling in online discussions, but direct clinical evidence for the combination is insufficient. Evidence about topical GHK-Cu on intact or laser-treated skin does not establish that needling it into skin is safe or more effective. Topical copper tripeptide complex after CO2 laser resurfacing (small study)

The small study commonly cited for post-procedure GHK-Cu evaluated topical products after carbon-dioxide laser resurfacing. Thirteen participants completed it; it was not a study of at-home microneedling. Topical copper tripeptide complex after CO2 laser resurfacing (small study)
FDA says microneedling devices are not approved to deliver cosmetics, topical medications, vitamin solutions, drugs or blood products such as PRP into the skin. It also says the risks of combining microneedling with products that have not been evaluated are unknown. FDA
Microneedling disrupts the skin barrier. FDA lists infection, pigment changes, skin damage and reactions to applied skin-care products among potential risks. A serum sold for ordinary topical use should not be presumed sterile or suitable for use on disrupted skin. FDA
The American Academy of Dermatology recommends having microneedling performed by a medical doctor with appropriate skin-treatment expertise and following the clinician’s aftercare instructions. American Academy of Dermatology
Ask about the device, the practitioner’s training, every product that will touch the treated skin, and the plan for complications before the procedure begins.
Start with the concern, such as acne scars, wrinkles or hair loss, then evaluate microneedling and the proposed serum separately before considering the combination.
Continue your discovery
Explore first, compare your options, or save what matters so you can return when you are ready.
GHK-Cu, also called copper tripeptide-1 or copper peptide, is the peptide most frequently marketed or discussed with microneedling. That popularity does not establish that the combination is safe or effective.
Do not assume so. A product intended for intact skin may be manufactured as a cosmetic rather than as a sterile product for use in punctured skin.
No. Exosomes are cell-derived vesicles, while PDRN and polynucleotides are DNA-derived materials. They require separate evidence and regulatory evaluation.
No. FDA says microneedling devices are not cleared to deliver cosmetics, topical medicines, vitamins, drugs or blood products into the skin.
Medical microneedling involves device authorization, practitioner training, infection control and professional follow-up. FDA says authorized medical microneedling devices have not been authorized for over-the-counter sale.
Last reviewed September 28, 2026. Every source above was checked on or before that date. Educational information only, not medical advice; it does not replace a conversation with a licensed clinician. DiscoverMedica does not employ clinicians.
A copper peptide common in skin-care serums. Injectable versions are not approved.